Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life [QOL] of Patients With Parkinson's Disease.
Phase of Trial: Phase IV
Latest Information Update: 01 Apr 2017
At a glance
- Drugs Levodopa/carbidopa/entacapone (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms QUEST-AP-1
- Sponsors Novartis
- 23 Nov 2007 The expected completion date for this trial is now 1 Jun 2006.
- 31 Oct 2006 Results have been reported.
- 20 Nov 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History